Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Klin Khir ; (7): 54-7, 2016.
Article in Ukrainian | MEDLINE | ID: mdl-30256595

ABSTRACT

Erysipelas (PB) ­ a serious disease that is accompanied by severe complications and high lethality. The immunological investigations were carry out in 51 patients who were treated at the clinic for erysipelas with an immunomodulator application. Marked changes in the indices of phagocytic activity of monocytes (PHAM) and the cytokine profile in patients with erysipelas were note. Application in complex treatment of immunomodulator give the positive effect on the indices of PHAM.


Subject(s)
Erysipelas/drug therapy , Immunity, Innate/drug effects , Immunologic Factors/therapeutic use , Monocytes/drug effects , Phagocytosis/drug effects , Adult , Aged , Aged, 80 and over , Angiogenesis Inducing Agents/therapeutic use , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Anticoagulants/therapeutic use , Erysipelas/blood , Erysipelas/immunology , Erysipelas/pathology , Female , Histamine Antagonists/therapeutic use , Humans , Interleukins/blood , Interleukins/immunology , Male , Middle Aged , Monocytes/immunology , Severity of Illness Index , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...